Secondary Logo

Journal Logo

The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.

Email: [email protected]


Current Urology is an international peer-reviewed journal providing practical, timely, and state-of-the-art contributions on clinical research and experience in urology.

The journal encompasses all aspects of basic urological research, clinical diagnosis, surgical and medical oncology, radiology, pathology, urolithiasis, andrology, reconstruction surgery, pediatric urology, female urology and urodynamics, erectile dysfunction, infertility, urinary infections and inflammations, endourology, and transplantation. Each issue contains reviews, original articles, methodology articles, case reports, commentaries and Letter to the Editor. It is published online.

Urologists, oncologists, pathologists, radiologists and scientists are invited to hand in their contributions to make Current Urology a viable international forum on latest findings in research and practice in urology.

Current Urology is sponsored by Shandong University.


All manuscripts must be submitted online at:

First-time Users

Please click the Register button at Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register. ​


Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system.​


Duplicate Publication 

Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Current Urology and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in Current Urology to plagiarism-detection software. 

This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.

Disclosure of Conflicts 

Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example: “Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors none were declared."


Current Urology expects that each person listed as an author has participated suffi­ciently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.

Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author's specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:

  • Participated in research design
  • Participated in the writing of the paper​
  • Participated in the performance of the research
  • Contributed new reagents or analytic tools
  • Participated in data analysis 
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.

English Language Assistance​

Appropriate use of the English language is a requirement for publication in Current Urology. Authors who have difficulty in writing in English who submit manuscripts to international journals often receive negative comments from referees or editors about the English-language usage in their manuscripts, and these challenges can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors consider using Wolters Kluwer Author Services**. ​

Wolters Kluwer Author Services

Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript:
  • Premium Editing: Intensive language and structural editing of academic papers to increase changes of journal acceptance.
  • Advanced Editing: A complete language, grammar, and terminology check to give you a publication-ready manuscript.
  • Translation with Editing: Write your paper in your native language and Wolters Kluwer Author Services will translate it into English, as well as edit it to ensure that it meets international publication standards.
  • Plagiarism Check: Helps ensure that your manuscript contains no instances of unintentional plagiarism.
  • Artwork Preparation: Save precious time and effort by ensuring that your artwork is viewed favorably by the journal without you having to incur the additional cost of purchasing special graphics software.
For more information regarding Wolters Kluwer Author Services, please visit

**Note that the use of such a service is at the author's own expense and risk, and does not guarantee that the article will be accepted.

Reporting of Randomized Clinical Trials

Registration of Clinical Trials is an essential requirement for publication of clinical trials in Current Urology. On the title page of your manuscript, provide the name of the trial registry and the registration number/identifier of the trial.

Acceptable web-based clinical trial registries include the following:

Reports of randomized clinical trials should follow the recommendations given in the Con­solidated Standards of Reported Trials (CONSORT) statement In brief, this statement comprises a checklist and flow diagram to help improve the quality of reports of randomized controlled trials and offers a standard way for researchers to report trials. 

Optional Reporting Guidelines

The following resources may be helpful to authors:

Qualitative Research

Qualitative research provides in-depth insights about people's values, attitudes, beliefs, and experiences. Qualitative methodology informs approaches to data collection and analysis, and includes grounded theory, ethnography, and phenomenology. Open-ended interviews and focus groups are commonly used to collect data. Authors are advised to follow the COREQ guidelines for reporting primary qualitative research. Please visit:

Systematic review and/or synthesis of primary qualitative studies can provide a broader understanding of people's perspectives across different healthcare contexts. Methodologies for synthesis of qualitative research include thematic synthesis, meta-ethnography and critical interpretive synthesis. Authors can refer to the ENTREQ statement at

Financial Support and Competing Interests

A financial disclosure section is part of the submission process and must be completed by each author at first revision. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.

The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an indi­vidual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals at the following link:

Peer Review

All articles published in Current Urology are subject to review initially by the Editorial team. Authors submitting manuscripts to Current Urology may propose suitable reviewers. Authors may oppose reviewers who may have competing interests. The final selection of reviewers is up to the editor. Manuscripts are accepted on the basis of quality, originality, significance, novelty and importance for the field. Only the manuscripts that best meet editorial standards are considered to send for external review. Manuscripts not sent to external review are rejected immediately.

Manuscripts that are found suitable for publication in Current Urology will be sent to two or more expert reviewers. Current Urology follows a single-blind peer-review process, where reviewers are aware of the author(s) but the reviewer are withheld. The Editor-in-Cheif will make a decision based on the suggestions or comments returned by reviewers:

a. Accept, with or without redaction and modification

b. Revise, the author shall make modifications according to the opinions or comments of reviewers before the final decision is made

c. Reject, but it is indicated to the author that it may be resubmitted after further improvement

d. Reject before review, it is usually based on insufficient quality, originality, significance, novelty, etc.

Types of Manuscripts Published

Type Text Word Guideline* Abstract Word Guideline Figure/Table Guideline Reference Guideline
Original Article2,500 - 6,000.  There is no explicit limit on the length of papers submitted, but authors are encouraged to be concise

300 max, structured into:

 Background, Materials and Methods, Results, and Conclusions

Each table should be numbered and cited in sequence using Arabic numerals (i.e., Table 1, 2, 3, etc.). Titles for tables should appear above the table and be no longer than 15 words

Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder(s) to reproduce figures or tables that have previously been published elsewhere.

Numbered consecutively, in square brackets, in the order in which they are cited in the text, and should be formatted in the National Library of Medicine style

Citations in the reference list should include all named authors, up to the first 6, before adding 'et al.'. Any in press articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

ReviewSame as Original Article350 words unstructuredAs aboveAs above
Case Report800 – 2,000150 words, unstructuredAs aboveAs above
Commentary800 – 2,000No abstractAs aboveAs above
MethodologySame as Original Article

300 max, structured into:

 Background, Methods, Results and Conclusions

As aboveAs above
Letter to the Editor1,000 – 3,000 No abstractAs aboveAs above
EditorialNo less than 800No abstractAs aboveAs above


  • Original Articles: reports of data from original research. These articles must describe significant and original observations. Consideration for publication is based on the article's originality, novelty, and scientific soundness, and the appropriateness of its analysis.

  • Reviews: comprehensive, authoritative, descriptions of any subject within the scope of the journal.  They are state-of-the-art papers covering a current topic by experts in the field. These articles should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
  • Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association or present an important adverse reaction. Authors should clearly describe the clinical relevance or implications of the case. All case report articles should indicate that informed consent to publish the information has been granted from the patients or their guardians.
  • Commentaries: short, focused, opinion articles on any subject within the scope of the journal. These articles are usually related to contemporary issues, such as recent research findings, and are often written by experts in the field who have been invited by the Editorial Board.
  • Methodology articles: present a new experimental or clinical method, test, procedure or technique. The method described may be new, or may offer a better version of an existing method.
  • Letter to the Editor: these can take three forms: a substantial re-analysis of a previously published article; a substantial response to such a re-analysis from the authors of the original publication; or an article that may not cover 'standard research' but that may be relevant to readers.
  • Editorial: Editorials are invited articles to explain the importance of specific articles or to provide opinions on general concepts in practice, research or policy. Editorials have no abstract and a minimum length of 800 words.

Manuscript Preparation and Formating Instructions

Manuscripts must be written in clear, grammatical English (see English Language Assistance above). Manuscripts not conforming to Journal format will be returned to authors for modification. Please double space the entire main body document and number each page. Do not add line numbers as the system will generate those when the PDF is built. 

Cover letter (optional)

Cover letter should include the name(s) and contact information of the corresponding author(s). Include the title of the manuscript, describe the rationale behind the study and the major findings from the research. Also state other issues, including duplicate publication, conflicts of interest and ethical approval statements.

Title page, footnotes, abbreviations, and abstract pages must be included in the main body file. Please do not upload separate copies of these documents.

Acceptable document file types for text and tables include .DOC and .DOCX; do not submit a PDF.

Page 1:

Title Page. The following elements are required for every submission:

Title. Include a descriptive title of the work; the title should not be a sentence. No proprietary or brand names for drugs or agents may be used in article titles.

Authors. The full first name, middle initials, and family name of each author, as well as the name(s) of the department(s) and institution(s) to which the work should be attributed.

Address for Correspondence. A current email and full mailing address for the corresponding author must be provided.

Funding. Include disclosure of funding received for this work, especially details of funding from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; and Howard Hughes Medical Institute (HHMI).

Disclosure. If the author(s) have no funding to disclose, please include the phrase, “The authors declare no conflicts of interest."

Page 2:

Footnotes. These should be designated by superscript Arabic numbers and should include:

Title: List each author's specific contributions to the work (see details above, under Authorship); list all forms of support received by each author for this study; list any potential conflict of interest for each author, or make a declaration of no conflict of interest.

Authors' names: List current email addresses for each author.

Text: Provide these in numerical sequence.

Footnotes for other than the above are not permitted in the manuscript body.

Page 3: 

Abbreviations. This page should list abbreviations not likely to be famil­iar to the reader. They should be listed alphabetically with their meanings. Please do not abbreviate terms unless they are used frequently. ​

Page 4: 

AbstractWhere required, abstracts are limited to 250 words, which is included in the overall manuscript word count. The abstract for reviews may be unstructured. The abstract for Articles and Short Reports should be struc­tured into four paragraphs, labeled Background, Materials and Methods, Results, and Con­clusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results. 

Main Body: 

Introduction. The introduction contains a statement of the purpose of the work, the problem that stimulated it, and a brief summary of relevant pub­lished investigations.

Materials and Methods. Avoid detailed description of previously published methods and cite the appropriate ref­erence. Detailed methods may be provided as Supplemental Digital Content and will appear in the online version only.

Results. The results should be concise, avoiding redundant tables and figures illustrating the same data.

Discussion. This section should follow the results and is used to in­terpret results, with minimal recapitulation of findings.

Acknowledgments: This section normally includes sources of research funds, the names of collaborators who are not listed as coauthors, or of any others who contributed to the manuscript. Where a medical writer or editorial assistant has been used to write or edit the article, the writer must be identified and named, together with the source of funding. 

References: The journal uses American Medical Association (AMA) style. References should begin on a separate page and numbered in the order in which they are cited in the text, where they are designated by superscript numbers placed outside periods and commas, and inside colons and semicolons. Only published works and manuscripts that have been accepted for publication should be listed in the References. Manuscripts in prepa­ration, unpublished observations, and personal communications should be re­ferred to in parentheses in the text. Completed manuscripts submitted for publication may be cited as footnotes to the text (see above, Footnotes). If these are subsequently accepted, the author may transfer them to the reference section in galley proof.

References Format. No more than six authors should be listed. If there are seven or more, only the first three followed by ''et al.'' should be included. Titles of journal articles must be included, and abbreviation of journal names should conform to Index Medicus style.

For information on AMA style, please visit

Two authors:

Ahmed KA, Xiang J. Mechanisms of cellular communication through intercellular protein transfer. J Cell Mol Med. 2011; 15(7): 1458.

More than seven authors:

Ali JM, Bolton EM, Bradley JA, et al. Allorecognition pathways in transplant rejection and tolerance. Transplantation 2013; 96(8): 681.

Organization as author:

CDC. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57: 1.

Donation after Circulatory Death. British Transplant Society. Available at: Accessed August 1, 2013.

Tables: Photographs of tables are not acceptable. Type each table, double-spaced through­out (including column headings, footnotes, and data), on a separate page. Tables may be included as part of the Main Body file and placed after the References section. Number the tables in sequence in Arabic numerals and supply a concise, informative title for each one. Each column in the tables should carry a concise heading describing the data in the column. Use lowercase superscript letters to designate footnotes, and type the footnotes below the tables to which they refer. Tables are cited in the text in numerical order. Each table should be able to be understood without consulting the text.

Like text, tables should be prepared using a standard word-processing program and may be included within the main body text document, or uploaded separately. Do not upload table files more than once (that is, in the main document and in separate files).

Acceptable document file types for tables include .DOC and .DOCX; do not submit PDF, XLS or XLSX type files.

Figures and Legends: Figures should be uploaded in the highest resolution available. Legends should be supplied for all figures. They are numbered to correspond with the figures and typed double-spaced on a separate page. Figure legends for any supplemental figures being submitted are to be provided separately; see section, Supplemental Digital Content (SDC). 

Acceptable figure file formats

  • Do not embed figures into the main body file
  • All final digital figures for accepted manuscripts must be submitted in EPS, TIFF, JPG. PowerPoint PPT format is permitted when the image resolution is very high.
  • Each figure must be uploaded as a separate file.
  • Histology figures must be in color.
  • Monochrome images (such as line graphs) should be prepared at a resolution of 1200 DPI.
  • Halftones images (black/white or color) should be prepared at a resolution of 300 DPI.
  • Combination halftones (images containing both pictures and text labeling) should be prepared at 600 DPI.
  • Color images must be saved as ''CMYK''. Images saved as ''RGB'' are not ac­ceptable for printing.
  • Your manuscript may be returned to you for correction if the images are of insufficient quality.
  • Artwork submitted to the Journal will be checked for quality. Authors submitting a revised paper will have the opportunity to check the quality of their images and make the necessary changes. This step is required for all revisions.

​Supplemental Digital Content (SDC): Authors may submit Supplemental Digital Content to supplement the information provided in the manu­script. It is preferable to include all significant figures and tables in the manuscript, since there is not a limit on the number of items in this online journal. Nonetheless, SDC may include the following types of content: text, tables, figures, references peripheral to information provided as SDC, audio, and video. SDC should be consecutively cited in the Main Body text of the submitted manuscript. SDC files will be available via URL(s) placed at the citation points within the article and are not copyedited by the publisher. Note that Journal policies for manuscript sub­mission relating to peer review, patient anonymity, ethics, financial disclosure, copyright, and permissions also apply to SDC. Authors should mask patients' eyes and remove patients' names from supplemental digital content unless they obtain written consent from the patients and submit them as supplemental files at the time of the manuscript submission.

Format, File Type and Size Requirements: SDC must be provided in one Word or PowerPoint file. Each SDC in the file should have a visual header in the following name format (e.g., ''SDC, Figure 1''; ''SDC, Materials and Methods'') and a corresponding citation must appear in the Main Body text. Note that SDC is numbered separately from non-SDC material. If providing SDC figure(s), a figure legend should be included on the figure itself. When uploading SDC select ''Supplemental Digital Content'' as the file designation. For audio and video files, also include the author name, videographer, participants, length (minutes), and size (MB). Video files should be formatted with a 320x240 pixel minimum screen size. For each submission, the SDC file cannot exceed a total size of 10 MB.​


New Submissions

Once the manuscript has been created, visit the submission site at to upload the manuscript. Once the manuscript has been vetted for compliance to the Journal's requirements, a manuscript number will be assigned to the submission. Failure to adhere to these guidelines will result in your manuscript being returned to you for correction. Faxed, scanned or emailed copies of manuscripts will not be accepted.

Revised Submissions

Mandatory author forms

Upon first revision, authors will be required to complete a License to Publish (LTP) form. LTP forms are required of every author listed on the submission. Please ensure each author's email address is properly listed on the footnotes page of your manuscript to avoid delays in reaching authors. Manuscripts will not pass to production without completed forms. LTP forms are available from the submission site homepage

All revised submissions require a point-by-point response to the reviewers' comments. Please upload this document as file type Response to Reviewers.

Changes made in the revised manuscript should be indicated using highlighted, bold or underlined text. Upload both a Marked and a Clean version of the revised manuscript. File types are provided for both versions.

A requirement of all revisions is the artwork quality check as described above (see Figures and Legends).

Revised manuscripts should be submitted within the deadline specified in the decision letter. Please contact us for an extension of the due date if it is not possible to submit the revision within that period, or should you desire to with­draw the manuscript from further consideration.

Revisions should adhere to original specifications for the submission type. Sometimes changes made in response to the decision/critiques may bring the revised manuscript out of compliance (e.g., over the word count and/or table/figure limit) with original specifications. This may be allowed by the Editor, but must be noted in the point-by-point response.

Submitting Invited Videos

Authors may want or be invited to submit videos to the Journal's website. The videos will serve to emphasize key aspects of the research findings reported in their soon to be published manuscript. Please visit Stand Alone Video Format Requirements to download full specifications and instructions for preparing these invited videos. 

Post Acceptance

Free language editing

For accepted papers by non-native English authors, the language consultants will perform a free language editing, including intensive check in language, grammar, and terminology. All the Language consultants are native English experts in related fields. ​

Page proofs

The publisher's Journal Production Editor will contact you when page proofs are ready for your review. The figures included on author's proofs are high resolution. Please inform the Journal Production Editor immediately if you have any questions concerning the quality of the figures on the proofs. For information regarding proofs, or the status of publication of your accepted manuscript, please contact current_urology[email protected]

Changes in corresponding author's contact information

Please give all new information, including email address, to the editorial office and to the publisher. Authors may send this information to Current Urology, [email protected], Fax: +86 531 85875736. If the Journal is unsuccessful in contacting the corresponding author, the author will not receive proofs for approval, and the manuscript may not be published. 

Changes at proofs

It is expected that the final manuscript sent to the Editor is indeed the final version, so few changes should be required at proof stage. 

Authors Retain Copyright

Authors retain their copyright for all articles. Authors grant WK a license to publish the article and identify itself as the original publisher. 

Open Access

Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs. Shandong University will pay to make the article open access.

Creative Commons Licenses

Open access articles will be freely available to read, download and share from the time of publication. Articles are published under the terms of the Creative Commons License Attribution-NonCommerical No Derivative 4.0 which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license visit

Editorial Office Contacts

The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with our guidelines.

Email: [email protected]

Submit a manuscript:​​